FindTrial
Sign In

Role of urinary NGAL and MCP-1 in predicting progression of diabetic kidney disease

Role of Novel Biomarkers Urinary NGAL and MCP-1 in Predicting Progression of Diabetic Kidney Disease in Type 2 DM

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036450
Enrollment
145
Registered
2021-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

None listed

Sponsors

Kasturba Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed with DKD as per KDIGO guidelines(CKD stage 1-3)based on CKD-EPI equation in Type 2 DM

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

MeasureTime frame
a. Worsening of proteinuria/New onset of micro albuminuria/ macro albuminuria.Timepoint: 1 year—

Primary

MeasureTime frame
Rapid progressors with eGFR decline of more than than 5ml/min /1.73m2 /yearTimepoint: 1 year—

Countries

India

Contacts

Public ContactSHILNA M S

Kasturba medical college Manipal

shankarmmcmed@gmail.com9739905443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026